THE HINDU, 13 August 2007 All further proceedings on the statutory appeals filed by Novartis, challenging the rejection of its patent application, pending before the Intellectual Property Appellate Board (IPAB) were stayed by the Madras High Court on Thursday. The First Bench comprising Chief Justice A.P. Shah and Justice P. Jyothimani granted the interim relief [...]
No Comments »
Filed under: News
BS Reporter / New Delhi August 8, 2007 The government of Switzerland will not be taking up the allegation by Novartis that Indian patent law is incompatible with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement at the dispute settlement board of the World Trade Organization (WTO). “We accept any case settled in India. [...]
No Comments »
Filed under: News
A division bench of the Madras High Court today dismissed a challenge to section 3(d) of the Indian Patents Act, 1970 filed by Swiss pharmaceutical multinational Novartis AG and its Indian subsidiary, Novartis India . These petitions challenged the validity of a key provision in the Indian law, which seeks to prevent ever greening and [...]
No Comments »
Filed under: News
Daily News & Analysis, August 02 ,2007 Novartis has moved the Madras High Court on Wednesday against the Intellectual Property Appellate Boards (IPAB) decision in the Glivec case, in which the company is fighting the case to obtain a patent on its anti-cancer drug. On July 20, IPAB shot down Novartis appeal to drop former [...]
No Comments »
Filed under: News
The Economic Times 2 August 2, 2007 Triggering a fresh legal wrangle, Swiss drug major Novartis on Wednesday filed a writ petition with the Madras High Court contesting the Intellectual Property Appellate Board (IPAB)s decision to let former Patent Controller General S Chandrasekaran hear its appeal for Glivec. Novartis had filed a petition with the [...]
No Comments »
Filed under: News
Novartisboycott tagged on Del.icio.us